Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility
暂无分享,去创建一个
Eleanor M Pullenayegum | E. Pullenayegum | F. Xie | Feng Xie | Kelvin K. W. Chan | Kelvin K W Chan | K. K. Chan
[1] G. Torrance. Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.
[2] David J Spiegelhalter,et al. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling , 2003, Statistics in medicine.
[3] Adrian E. Raftery,et al. [Practical Markov Chain Monte Carlo]: Comment: One Long Run with Diagnostics: Implementation Strategies for Markov Chain Monte Carlo , 1992 .
[4] Deborah J Street,et al. Time trade-off derived EQ-5D weights for Australia. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] John Geweke,et al. Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments , 1991 .
[6] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[7] Jason N Doctor,et al. Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT) , 2013, Health and Quality of Life Outcomes.
[8] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[9] D. Street,et al. International comparisons in valuing EQ-5D health states: a review and analysis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] Anthony O'Hagan,et al. Modelling SF-6D health state preference data using a nonparametric Bayesian method. , 2007, Journal of health economics.
[11] Anthony O'Hagan,et al. Estimating utilities from individual health preference data: a nonparametric Bayesian method , 2005 .
[12] John E. Brazier,et al. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.
[13] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[14] Philip Heidelberger,et al. Simulation Run Length Control in the Presence of an Initial Transient , 1983, Oper. Res..
[15] Remko Soer,et al. Clinimetric properties of the EuroQol-5D in patients with chronic low back pain. , 2012, The spine journal : official journal of the North American Spine Society.
[16] Jose Leal,et al. How important is parameter uncertainty around the UK EQ-5D-3L value set when estimating treatment effects? , 2012 .
[17] James S. Dyer,et al. Maut — Multiattribute Utility Theory , 2005 .
[18] Roger A. Sugden,et al. Multiple Imputation for Nonresponse in Surveys , 1988 .
[19] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[20] Anthony O'Hagan,et al. Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method. , 2007, Social science & medicine.
[21] M. Neary,et al. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer , 2010, Health and Quality of Life Outcomes.
[22] P. J. Huber. The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .
[23] H. White. Maximum Likelihood Estimation of Misspecified Models , 1982 .
[24] K. Perampaladas,et al. Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist , 2013 .